| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5705479 | Ophthalmology | 2017 | 8 Pages |
Abstract
This prospective, randomized trial found that treat and extend dosing of ranibizumab 0.3 mg with and without angiography-guided macular laser photocoagulation significantly decreased the number of injections given while providing similar visual and anatomic outcomes compared with monthly dosing at 1 year. Adding angiography-guided laser photocoagulation to this dosing algorithm did not significantly improve outcomes at 1 year.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
John F. MD, Charles C. MD, W. Lloyd MD, Beau B. MD, PhD, David S. MD, David M. MD, TREX-DME Study Group TREX-DME Study Group,